Herbalife Ltd. (Form: 8-K)  






Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):   April 23, 2008

Herbalife Ltd.
(Exact name of registrant as specified in its charter)

Cayman Islands 1-32381 98-0377871
(State or other jurisdiction
(I.R.S. Employer
of incorporation) File Number) Identification No.)
P.O. Box 309GT, Ugland House, South Church Street, Grand Cayman, Cayman Islands   00000
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code:   c/o (310) 410-9600

Not Applicable
Former name or former address, if changed since last report


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Top of the Form

Item 8.01 Other Events.

The following information is furnished pursuant to Item 8.01, Other Events.

On April 23, 2008, Herbalife Ltd. issued a press release with respect to the Ministerio de Sanidad Y Consumo, Spain's Ministry of Health issuance of a "recommendation of precaution when consuming products of the Herbalife brand." A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(c) Exhibits

Press Release issued by Herbalife Ltd. on April 23, 2008

Top of the Form


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Herbalife Ltd.
April 24, 2008   By:   Brett R. Chapman
        Name: Brett R. Chapman
        Title: General Counsel

Top of the Form

Exhibit Index

Exhibit No.   Description

  Press Release issued by Herbalife Ltd. on April 23, 2008
Media Contact:
  Investor Contact:
Barbara Henderson
SVP, Worldwide Corp. Comm.
(310) 410-9600 ext. 32736
  Erin Gehan
Sr. Director Investor Relations
(310) 410-9600 ext. 32862

Herbalife Responds to Spanish Ministry of Health Alert

LOS ANGELES, April 23, 2008 — Herbalife Ltd. (NYSE: HLF) issued a statement in response to a Spanish Ministry of Health alert.

On April 21, 2008, the Ministerio de Sanidad Y Consumo, Spain’s Ministry of Health, issued a “Recommendation of precaution when consuming products of the Herbalife brand.” The company is in an ongoing discussion with the agency and is providing the final section of its dossier on April 23, 2008 as previously agreed. As the company has noted in its previous public filings, from time to time it receives inquiries such as the one from Spain and cooperates fully with the authority involved.  Herbalife will continue to cooperate with Spanish authorities to help them more fully understand the scientific issues involved and the safety of our products.

The alert cites caution due to “suspicious cases” of “hepatic toxicity presumably associated with the consumption of products from Herbalife.” No specific product or ingredient that might have contributed to liver problems is named in the alert.  Herbalife has an adverse event reporting procedure that deals with the small number of queries we receive from doctors and consumers and we have an open dialogue with the medical community.  All adverse event reports are investigated thoroughly in consultation with the consumer and the physician (if available) to fully understand the facts.  In the United States, Herbalife strongly supported legislation mandating the submission of all dietary supplement and over-the-counter drug serious adverse events to the Food & Drug Administration. That law took effect in December 2007.

For more than 28 years, tens of millions of Herbalife consumers worldwide have been safely using Herbalife products with an extremely low incidence of serious adverse event reports citing liver function abnormalities.

Herbalife operates in 65 countries and has in excess of 400 products in its product range.  In Spain, the company sells 48 products, including products for skin and hair care such as facial creams, shampoo and soap.  In its recommendation, the Spanish Ministry of Health also questioned whether the company’s distribution model would hinder its ability to trace the sales of its products.  The company believes that its business model actually enhances its ability to follow up on product sales since it is able to contact its network of 1.7 million distributors worldwide in the event of a product issue, who in turn can contact their customers.  Retail stores or other sales methods may not have records of individual consumer purchases.

“Our 1.7 million Herbalife Independent Distributors are aware of the benefits of our products,” said Michael O. Johnson, chairman and chief executive officer of Herbalife.  “Along with our scientific and medical staff and advisors, they are confident in our science. For more than 28 years, our Distributors have worked closely with their customers to achieve healthier lives by combining the use of our products with moderate exercise and a healthy, active lifestyle.”

 About Herbalife Ltd.

Herbalife Ltd. is a global network marketing company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 65 countries through a network of over 1.7 million independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to bring good nutrition to children. Please visit Herbalife Investor Relations for additional financial information.